Neurologic involvement in patients with atypical Chediak-Higashi disease

Wendy J Introne¹, Wendy Westbroek², Catherine A Groden², Vikas Bhambhani², Gretchen A Golas², Eva H Baker², Tanya J Lehky², Joseph Snow², Shira G Ziegler², May Christine V Malicdan², David R Adams², Heidi M Dorward², Richard A Hess², Marjan Huizing², William A Gahl², Camilo Toro²

Affiliations

¹ From the Office of the Clinical Director (W.J.I., C.A.G., V.B., G.A.G., W.A.G., C.T.) and Human Biochemical Genetics Section, Medical Genetics Branch (W.W., S.G.Z., M.C.V.M. D.R.A., H.M.D., R.A.H., M.H., W.A.G.), National Human Genome Research Institute, Department of Radiology and Imaging Sciences, Clinical Center (E.H.B.), Electromyography Section, Office of the Clinical Director, National Institute of Neurological Disorders and Stroke (T.J.L.), and Office of the Clinical Director, National Institute of Mental Health (J.S.), National Institutes of Health, Bethesda, MD; and Metabolic and Clinical Geneticist (V.B.), Department of Medical Genetics, Children's Hospitals and Clinics of Minnesota, Minneapolis. wintrone@mail.nih.gov.
² From the Office of the Clinical Director (W.J.I., C.A.G., V.B., G.A.G., W.A.G., C.T.) and Human Biochemical Genetics Section, Medical Genetics Branch (W.W., S.G.Z., M.C.V.M. D.R.A., H.M.D., R.A.H., M.H., W.A.G.), National Human Genome Research Institute, Department of Radiology and Imaging Sciences, Clinical Center (E.H.B.), Electromyography Section, Office of the Clinical Director, National Institute of Neurological Disorders and Stroke (T.J.L.), and Office of the Clinical Director, National Institute of Mental Health (J.S.), National Institutes of Health, Bethesda, MD; and Metabolic and Clinical Geneticist (V.B.), Department of Medical Genetics, Children's Hospitals and Clinics of Minnesota, Minneapolis.

PMID: 28193763
PMCID: PMC5584077
DOI: 10.1212/WNL.0000000000003622

Neurologic involvement in patients with atypical Chediak-Higashi disease

Wendy J Introne et al. Neurology. 2017.

. 2017 Feb 14;88(7):e57-e65.

doi: 10.1212/WNL.0000000000003622.

Authors

Affiliations

¹ From the Office of the Clinical Director (W.J.I., C.A.G., V.B., G.A.G., W.A.G., C.T.) and Human Biochemical Genetics Section, Medical Genetics Branch (W.W., S.G.Z., M.C.V.M. D.R.A., H.M.D., R.A.H., M.H., W.A.G.), National Human Genome Research Institute, Department of Radiology and Imaging Sciences, Clinical Center (E.H.B.), Electromyography Section, Office of the Clinical Director, National Institute of Neurological Disorders and Stroke (T.J.L.), and Office of the Clinical Director, National Institute of Mental Health (J.S.), National Institutes of Health, Bethesda, MD; and Metabolic and Clinical Geneticist (V.B.), Department of Medical Genetics, Children's Hospitals and Clinics of Minnesota, Minneapolis. wintrone@mail.nih.gov.
² From the Office of the Clinical Director (W.J.I., C.A.G., V.B., G.A.G., W.A.G., C.T.) and Human Biochemical Genetics Section, Medical Genetics Branch (W.W., S.G.Z., M.C.V.M. D.R.A., H.M.D., R.A.H., M.H., W.A.G.), National Human Genome Research Institute, Department of Radiology and Imaging Sciences, Clinical Center (E.H.B.), Electromyography Section, Office of the Clinical Director, National Institute of Neurological Disorders and Stroke (T.J.L.), and Office of the Clinical Director, National Institute of Mental Health (J.S.), National Institutes of Health, Bethesda, MD; and Metabolic and Clinical Geneticist (V.B.), Department of Medical Genetics, Children's Hospitals and Clinics of Minnesota, Minneapolis.

PMID: 28193763
PMCID: PMC5584077
DOI: 10.1212/WNL.0000000000003622

Abstract

Objective: To delineate the developmental and progressive neurodegenerative features in 9 young adults with the atypical form of Chediak-Higashi disease (CHD) enrolled in a natural history study.

Methods: Patients with atypical clinical features, but diagnostically confirmed CHD by standard evaluation of blood smears and molecular genotyping, underwent complete neurologic evaluation, MRI of the brain, electrophysiologic examination, and neuropsychological testing. Fibroblasts were collected to investigate the cellular phenotype and correlation with the clinical presentation.

Results: In 9 mildly affected patients with CHD, we documented learning and behavioral difficulties along with developmental structural abnormalities of the cerebellum and posterior fossa, which are apparent early in childhood. A range of progressive neurologic problems emerge in early adulthood, including cerebellar deficits, polyneuropathies, spasticity, cognitive decline, and parkinsonism.

Conclusions: Patients with undiagnosed atypical CHD manifesting some of these wide-ranging yet nonspecific neurologic complaints may reside in general and specialty neurology clinics. The absence of the typical bleeding or infectious diathesis in mildly affected patients with CHD renders them difficult to diagnose. Identification of these individuals is important not only for close surveillance of potential CHD-related systemic complications but also for a full understanding of the natural history of CHD and the potential role of the disease-causing protein, LYST, to the pathophysiology of other neurodevelopmental and neurodegenerative disorders.

PubMed Disclaimer

Conflict of interest statement

The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.

Figures

**Figure 1.. Hair and skin pigmentation, blood smears, and hair microscopy of representative patients with atypical Chediak-Higashi disease (CHD)**
(A) Hair and skin pigmentation. (B) Characteristic giant inclusions (arrows) within neutrophils are numerous and variable in size. (C) A solitary giant inclusion is typically seen within lymphocytes. (D) Light microscopy reveals atypical pigment clumping within hair shafts. Note uniform distribution of pigment in normal hair (CHD-5 inset).

**Figure 2.. LYST protein expression and lysosome size and distribution in Chediak-Higashi disease (CHD) fibroblasts**
(A) High-molecular-weight immunoblots of protein extracts from normal control fibroblasts (lane 7), classic LYST-negative control fibroblasts CHD-16 (lane 3) and CHD-4 (lane 6), and 4 different CHD patients' fibroblast cultures; α-tubulin was used as a loading control. Fibroblasts from patients with atypical CHD (CHD-18, lane 1; CHD-17, lane 2; CHD-6, lane 4; and CHD-5, lane 5) have reduced levels of LYST expression. CHD-5 cells showed no LYST protein, despite the presence of a low level of residual RNA (∼20% of control). Please refer to our previous publication [Manoli I, Golas G, Westbroek W, et al. Chediak-Higashi syndrome with early developmental delay resulting from paternal heterodisomy of chromosome 1. Am J Med Genet A 2010;152A:1474–1483] for methods and antibody information. (B) Fibroblasts are stained with LAMP-1 antibodies (green) to visualize lysosomal membranes and with an F-actin marker (phalloidin, red) to visualize the cell boundaries. Control fibroblasts show a typical distribution of lysosomes throughout the cell. Classic CHD-4 fibroblasts show enlarged lysosomes restricted to the perinuclear area. CHD-5 fibroblasts show enlarged lysosomes in the perinuclear area and normal-sized lysosomes in the periphery. CHD-6 fibroblasts show slightly enlarged lysosomes. CHD-17 and CHD-18 fibroblasts have slightly enlarged lysosomes with a typical distribution of lysosomes throughout the cell. Marked white dotted squares in left panels are zoomed out in right panels. Scale bar 20 μm.

**Figure 3.. Brain MRIs of patients with atypical Chediak-Higashi disease (CHD)**
Midline MRI sagittal images for 6 patients with atypical CHD obtained at the time of their initial evaluation. (A–F) Patients CHD-6, 19, 24, 17, 23, and 20. The tentorial angle (in degrees) and lines converging on the tentorial angle are represented for each image. (G) Similarly processed image in one representative age-matched control. (H, I) Coronal MRI views at the level of the cerebellar hemispheres for mild (case CHD-23) and advanced (case CHD-20) neurologic impairment demonstrate cerebral and cerebellar atrophy in the more severely affected patient.

See this image and copyright information in PMC

Retracted and republished from

Neurologic involvement in patients with atypical Chediak-Higashi disease.
Introne WJ, Westbroek W, Cullinane AR, Groden CA, Bhambhani V, Golas GA, Baker EH, Lehky TJ, Snow J, Ziegler SG, Adams DR, Dorward HM, Hess RA, Huizing M, Gahl WA, Toro C. Introne WJ, et al. Neurology. 2016 Apr 5;86(14):1320-1328. doi: 10.1212/WNL.0000000000002551. Epub 2016 Mar 4. Neurology. 2016. Retracted and republished in: Neurology. 2017 Feb 14;88(7):e57-e65. doi: 10.1212/WNL.0000000000003622. PMID: 26944273 Free PMC article. Retracted and republished.

References

1. Nagle DL, Karim MA, Woolf EA, et al. . Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996;14:307–311. - PubMed
1. Blume RS, Wolff SM. The Chediak-Higashi syndrome: studies in four patients and a review of the literature. Medicine 1972;51:247–280. - PubMed
1. Jessen B, Maul-Pavicic A, Ufheil H, et al. . Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. Blood 2011;118:4620–4629. - PubMed
1. Introne W, Boissy RE, Gahl WA. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 1999;68:283–303. - PubMed
1. Tardieu M, Lacroix C, Neven B, et al. . Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. Blood 2005;106:40–42. - PubMed

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Neurologic involvement in patients with atypical Chediak-Higashi disease

Affiliations

Neurologic involvement in patients with atypical Chediak-Higashi disease

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Retracted and republished from

References

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources